Danaher CEO Comments on Outlook
January 8, 2013
Washington, D.C.,- Danaher Corporation (NYSE:DHR) announced that its President and Chief Executive Officer, H. Lawrence Culp, Jr., will comment tomorrow on the Company's performance in a presentation at the J.P. Morgan Healthcare Conference in San Francisco, CA. Mr. Culp will communicate that the Company's fourth quarter 2012 diluted net earnings per share is anticipated to [...]
IntelligentMDx Enters into an Agreement with QIAGEN to Develop and Manufacture Molecular Tests
January 7, 2013
CAMBRIDGE, MASSACHUSETTS –— IntelligentMDx (privately held) announced today that it has entered into a multi-year development and license agreement with QIAGEN (NASDAQ: QGEN, Frankfurt Prime Standard: QIA) to design, develop and manufacture several undisclosed CE-marked and FDA cleared diagnostic tests for use on QIAGEN's flagship QIAsymphony RGQ automated platform. Financial terms have not been disclosed. [...]
Rolland Carlson, Ph.D. named CEO of Asuragen
January 7, 2013
Austin, Texas – Asuragen Inc., a leading molecular diagnostic company, announced today that Rollie Carlson, previously the President and Chief Operating Officer of the Company, has been appointed President and CEO. Matt Winkler, the founder and prior CEO of Asuragen, will retain the role of Chairman of the Board and Chief Scientific Officer. "I had [...]
January 7, 2013
SUNNYVALE, Calif. & HELSINKI -- Labcyte Inc. and the Institute for Molecular Medicine Finland (FIMM) are collaborating to further the development of personalized medicine in cancer treatment. Labcyte acoustic liquid handling technology has already revolutionized small-molecule research. Now, FIMM, a European leader in advanced research for new cancer therapies, will apply the technology extensively in [...]
Artel simplifies the verification of low-volume DMSO dispenses
January 7, 2013
Westbrook, ME – Artel is launching the first in a new line of 100% DMSO-based Sample Solutions for use with the MVS® Multichannel Verification System. These will provide users with the ability to measure the accuracy and precision of volumes of DMSO dispensed into microwell plates. The first in the new line of DMSO solutions [...]
Dako Enters Collaboration with Eli Lilly and Company for Development of Companion Diagnostics
January 7, 2013
Dako, an Agilent Technologies company, announced today it has entered into a master framework agreement with Eli Lilly and Company for the development of companion diagnostic tests to identify patients who may be more likely to benefit from an investigational oncology medicine currently under development by Lilly. The agreement constitutes a framework for collaboration between [...]
January 7, 2013
—Enables Simultaneous Analysis of Low to High Boiling Point Compounds— Shimadzu Corporation has launched the HS-20 gas chromatography headspace sampler for accurate analysis of a wide range of volatile compounds with low to high boiling points. Headspace samplers heat liquid or solid samples sealed in a container to a certain temperature, and introduce the volatile [...]
OriGene Publishes Landmark Paper on Revolutionary Proteome Platform for Antibody Specificity Test
January 7, 2013
ROCKVILLE, MD -- OriGene Technologies, Inc. (“OriGene”), one of the industry leaders in producing genome wide products for research and diagnostic applications, has brought the antibody field one step closer to identifying and developing ultra-specific monoclonal antibodies. Specificity of antibodies for research or clinical applications is of critical importance and therefore it is a "must" [...]
Risa Stack to Join GE Healthymagination Team
January 7, 2013
Menlo Park, CA – Kleiner Perkins Caufield & Byers (KPCB) announced today that Risa Stack, PhD., a long time partner at KPCB, has been named General Manager of GE’s Emerging Health Innovations, reporting to Sue Siegel, CEO of healthymagination. Stack has served for two years on the advisory board for healthymagination – GE’s $6 billion [...]
Bruker Corporation Appoints Joshua Young as Vice President of Investor Relations
January 7, 2013
BILLERICA, Mass.-- Bruker Corporation (NASDAQ: BRKR) today announced that it has appointed Joshua Young as Vice President of Investor Relations. Young will succeed Stacey Desrochers who will continue as a key member of Bruker's finance organization and will focus full-time on managing Bruker's worldwide Treasury operations. Desrochers was instrumental in strengthening Bruker's investor relations and [...]
